Rabbit Recombinant Monoclonal RRM2 antibody. Carrier free. Suitable for IP, WB, IHC-P, ICC/IF and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
IP | Flow Cyt | WB | IHC-P | ICC/IF | |
---|---|---|---|---|---|
Human | Tested | Not recommended | Tested | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Select an associated product type
Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. Inhibits Wnt signaling.
RR2, RRM2, Ribonucleoside-diphosphate reductase subunit M2, Ribonucleotide reductase small chain, Ribonucleotide reductase small subunit
Rabbit Recombinant Monoclonal RRM2 antibody. Carrier free. Suitable for IP, WB, IHC-P, ICC/IF and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ab240166 is the carrier-free version of Anti-RRM2 antibody [EPR11820] ab172476.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
RRM2 also known as Ribonucleotide Reductase Regulatory Subunit M2 is an important component of the ribonucleotide reductase enzyme complex which plays a significant part in DNA synthesis. This protein helps convert ribonucleotides into deoxyribonucleotides. RRM2 is approximately 45 kDa in size. Its expression occurs mostly in proliferating cells with high levels detected in the cytoplasm and nucleus. The expression level of RRM2 can vary significantly across different tissues correlating closely with cell division rates.
The ribonucleotide reductase enzyme facilitates the critical function of DNA replication and repair. RRM2 forms a complex with RRM1 the large subunit necessary for enzyme activity. This complex regulates the balance of deoxyribonucleotide pools necessary for DNA synthesis. Variations or dysregulations in the activity of RRM2 can influence genetic stability and cell proliferation emphasizing its importance in cellular function.
Ribonucleotide reductase and RRM2 participate significantly in the DNA synthesis and repair pathway. It is pivotal for maintaining DNA fidelity during replication. RRM2 actions relate to pathways involving other DNA replication proteins such as RRM1 and the replication factor C family. The synthesis pathway necessitates close cooperation between these proteins to ensure proper DNA replication and cell cycle progression.
Research has linked RRM2 to cancer and viral infections. Overexpression or mutations in the RRM2 gene may contribute to cancer development as seen in various tumor types indicating it as a potential target for cancer therapeutics. Moreover some viruses may hijack the host's RRM2 to facilitate their own replication. Targeting the RRM2 protein could potentially lead to novel treatment approaches in these diseases connecting it with other proteins like RRM1 which also share roles in tumor progression and viral replication.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-RRM2 antibody [EPR11820] ab172476, the same antibody clone in a different buffer formulation.
All lanes: Western blot - Anti-RRM2 antibody [EPR11820] (Anti-RRM2 antibody [EPR11820] ab172476) at 1/1000 dilution
Lane 1: HeLa cell lysate at 10 µg
Lane 2: HepG2 cell lysate at 10 µg
Lane 3: K562 cell lysate at 10 µg
Lane 4: Jurkat cell lysate at 10 µg
Predicted band size: 45 kDa
Western blot analysis on immunoprecipitation pellet from HeLa cell lysate (lane 1) labeling RRM2 with Anti-RRM2 antibody [EPR11820] ab172476 at 1/10 dilution or 1X PBS (lane 2) negative control. HRP-conjugated anti-Rabbit IgG preferentially detecting the non-reduced form of Rabbit IgG.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-RRM2 antibody [EPR11820] ab172476).
All lanes: Immunoprecipitation - Anti-RRM2 antibody [EPR11820] (Anti-RRM2 antibody [EPR11820] ab172476)
Predicted band size: 45 kDa
Immunofluorescent analysis of HeLa cells labeling RRM2 with Anti-RRM2 antibody [EPR11820] ab172476 at 1/100 dilution (red). DAPI nuclear staining (blue).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-RRM2 antibody [EPR11820] ab172476).
Immunohistochemical analysis of Paraffin-embedded sections Human Cerebrum tissue labelling RRM2 with Anti-RRM2 antibody [EPR11820] ab172476 at 1/1000 dilution, followed by LeicaDS9800 (Bond® Polymer Refine Detection)(Ready to use). Negative/low expression control: no staining in human cerebrum (PMID: 30745840). The section was incubated with Anti-RRM2 antibody [EPR11820] ab172476 for 30 mins at room temperature. Counterstained with Hematoxylin.
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is LeicaDS9800 (Bond® Polymer Refine Detection)(Ready to use). The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20 mins
This data was developed using Anti-RRM2 antibody [EPR11820] ab172476, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of Paraffin-embedded sections Human Colon carcinoma tissue labelling RRM2 with Anti-RRM2 antibody [EPR11820] ab172476 at 1/1000 dilution, followed by LeicaDS9800 (Bond® Polymer Refine Detection)(Ready to use). Positive staining on Human Colon carcinoma is observed. The section was incubated with Anti-RRM2 antibody [EPR11820] ab172476 for 30 mins at room temperature. Counterstained with Hematoxylin.
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is LeicaDS9800 (Bond® Polymer Refine Detection)(Ready to use).
Positive staining on human colon carcinoma. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20 mins.
This data was developed using Anti-RRM2 antibody [EPR11820] ab172476, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of Paraffin-embedded sections Human Stomach tissue labelling RRM2 with Anti-RRM2 antibody [EPR11820] ab172476 at 1/1000 dilution, followed by LeicaDS9800 (Bond® Polymer Refine Detection)(Ready to use).Human stomach staining on Human Stomach is observed. Counterstained with Hematoxylin.
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is LeicaDS9800 (Bond® Polymer Refine Detection)(Ready to use).
Positive staining in human stomach. The section was incubated with Anti-RRM2 antibody [EPR11820] ab172476 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20 mins.
This data was developed using Anti-RRM2 antibody [EPR11820] ab172476, the same antibody clone in a different buffer formulation.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com